THE R46L POLYMORPHISM OF PCSK9 GENE AND LIPID PROFILE IN CAUCASIAN POPULATION OF RUSSIA

被引：0
|
作者：
Astrakova, K. [1 ]
Shakhtshneider, E. [2 ]
Ivanoshchuk, D. [2 ]
Ragino, Y. [1 ]
Astrakov, S. [3 ]
Voevoda, M. [2 ]
机构：
[1] Inst Internal & Prevent Med, Biochem Lab, Novosibirsk, Russia
[2] Inst Internal & Prevent Med, Med Genet Lab, Novosibirsk, Russia
[3] Novosibirsk State Univ, Fac Med, Novosibirsk, Russia
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0875
引用
收藏
页码：E40 / E40
页数：1
相关论文
共 50 条
  • [31] Impact of PCSK9 gene polymorphism on atorvastatin efficacy in Iraqi hyperlipidemic patients
    Mohammed, Khalid Qasim
    Ouda, Mazin H.
    Jubair, Suzanne
    GENE REPORTS, 2025, 39
  • [32] Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9
    Li, Huihui
    Li, Jun
    Zhang, Xianjing
    Li, Jiaomeng
    Xi, Cong
    Wang, Wenqiong
    Lu, Youli
    Xuan, Lijiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (06)
  • [33] ASSOCIATION OF SERUM LIPID PROFILE WITH PEDIATRIC SEPTIC SHOCK OUTCOMES AND PCSK9 GENOTYPE
    Atreya, Mihir R.
    Whitacre, Brynne
    Wong, Hector
    SHOCK, 2020, 53 : 105 - 106
  • [34] UTILIZATION AND EFFECTIVENESS OF PCSK9 INHIBITORS IN IMPROVING LIPID PROFILE IN ROUTINE CLINICAL PRACTICE
    Yao, X.
    DeMartino, R.
    Lopez-Jimenez, F.
    Gersh, B. J.
    Sangaralingham, L. R.
    Shah, N. D.
    Noseworthy, P. A.
    VALUE IN HEALTH, 2017, 20 (05) : A277 - A278
  • [35] The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis
    Amélie Bonnefond
    Loïc Yengo
    Cédric Le May
    Fréderic Fumeron
    Michel Marre
    Beverley Balkau
    Guillaume Charpentier
    Sylvia Franc
    Philippe Froguel
    Bertrand Cariou
    Diabetologia, 2015, 58 : 2051 - 2055
  • [36] The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis
    Bonnefond, Amelie
    Yengo, Loic
    Le May, Cedric
    Fumeron, Frederic
    Marre, Michel
    Balkau, Beverley
    Charpentier, Guillaume
    Franc, Sylvia
    Froguel, Philippe
    Cariou, Bertrand
    DIABETOLOGIA, 2015, 58 (09) : 2051 - 2055
  • [37] An association analysis between a missense polymorphism at the pig PCSK9 gene and serum lipid and meat quality traits in Duroc pigs
    Chanski, Wojciech
    Gonzalez-Prendes, Rayner
    Castello, Anna
    Jordana, Jordi
    Manunza, Arianna
    Quintanilla, Raquel
    Amills, Marcel
    LIVESTOCK SCIENCE, 2016, 190 : 27 - 30
  • [38] PLASMA PCSK9 LEVELS ARE LOW IN HEALTHY SUBJECTS CARRYING THE PCSK9 P.R46L VARIANT AND IN P.D374Y FAMILIAL HYPERCHOLESTEROL-EMIA PATIENTS
    Humphries, S. E.
    Neely, D.
    Whittall, R. A.
    Troutt, J.
    Konrad, R. J.
    Scartezini, M.
    Li, Ka Wah
    Cooper, J. A.
    Acharya, J.
    Neil, H. A. W.
    ATHEROSCLEROSIS, 2009, 207 (01) : 307 - 307
  • [39] STRUCTURAL CHANGES BRACHIOCEPHALIC ARTERIES IN PATIENTS WITH CHD AND HEFH TAKING INTO ACCOUNT THE LEVEL OF PCSK9 AND GENETIC POLYMORPHISM E670G OF THE PCSK9 GENE
    Alieva, R.
    Shek, A.
    Kurbanov, R.
    Nizamov, U.
    Hochimov, S.
    ATHEROSCLEROSIS, 2019, 287 : E252 - E252
  • [40] Targeted Next-Generation Sequencing of PCSK9 Gene in Patients With Familial Hypercholesterolemia in Russia
    Shakhtshneider, E. V.
    Makarenkova, K. V.
    Astrakova, K. S.
    Ivanoshchuk, D. E.
    Orlov, P. S.
    Ragino, Yu. I.
    Voevoda, M. I.
    KARDIOLOGIYA, 2017, 57 (06) : 46 - 51
12345